The Drug Abuse Testing Market size is expected to grow at an annual average of 16% during 2021-2027. Commercial protocols for drug abuse testing have undergone significant changes in recent years to keep pace with the ever-increasing demand for new substances, alternative matrices, and markets being abused. Substance abuse testing is a non-invasive technical analysis of biological samples such as blood, hair, urine, etc. to diagnose the presence of illegal, prescription drugs or their metabolites.
(Get 15% Discount on Buying this Report)
A full report of Drug Abuse Testing Market is available at: https://www.orionmarketreports.com/drug-abuse-testing-market/38811/
The following segmentation are covered in this report:
By End User
- Workplaces & Schools
- Criminal Justice Systems and Law Enforcement Agencies
- Research Laboratories
- Hospitals
By Product & Services
- Analyzers
- Consumables
- Rapid Testing Devices
- Laboratory Services
By Sample Type
- Urine
- Oral Fluid (Saliva)
- Hair
- Breath
- Others
Company Profile
- Quest Diagnostics
- Abbott Laboratories
- Clinical Reference Laboratory (CRL), Inc.
- Laboratory Corporation of America Holdings
- Cordant Health Solutions
- Legacy Medical Services
- DrugScan
- Omega Laboratories, Inc.
- Psychemedics Corporation
- Millennium Health
- Mayo Clinic Laboratories
The report covers the following objectives:
- Proliferation and maturation of trade in the global Drug Abuse Testing Market
- The market share of the global Drug Abuse Testing Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Drug Abuse Testing Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Drug Abuse Testing Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
